David S. Rosenbaum, M.D., is the chief of Cardiology and director of the Heart & Vascular Center for The Metro Health System and Professor of Medicine, Biomedical Engineering, Physiology and Biophysics at Case Western University (CWRU). He received his cardiology and clinical electrophysiology training atMassachusetts GeneralHospital, and post-doctoral research training in the Harvard-MIT Division of Health Sciences and Technology.
As an internationally recognized cardiologist, scientist, and thought leader he has served on editorial boards in numerous leadership roles in professional societies. He is currently Chairs both the Research Health Policy Committee and the Basic Science Program Committee for the Heart Rhythm Society (HRS), and serves on the Cardiac Electrophysiology Committee for the American College of Cardiology. He as served on multiple advisory panels and research study sections at the National Institutes of Health, AHA, and NASA, He has been particularly involved in programs devoted to young physician scientist, serving on Young Investigator Award committees mentoring trainees in CWRU Medical Scientist Training Program, and numerous PhD and post-doctoral trainees, and is Director of MetroHealth’s Physician Scientist Program (PSP). In 1999, he established theHeart & VascularResearchCenterat MetroHealth, a state-of-the-art facility for training cardiovascular investigators.
Under his leadership, the Metro Health Heart & Vascular Center has initiated several pioneering cardiovascular research studies. These include developing new methods for predicting and preventing sudden cardiac death (SCD), as well as the development of novel paradigms for preventing arrhythmias using targeted gene therapy. His research contributions span from the “bench to the bedside”, including the identification of T wave alternans as a marker for SCD in humans, and more recently describing molecular mechanisms for cardiac alternans responsible for triggering electrical instability in the heart.
